Aura Biosciences Inc (AURA)
8.48
-0.15
(-1.74%)
USD |
NASDAQ |
Dec 04, 16:00
8.48
0.00 (0.00%)
After-Hours: 20:00
Aura Biosciences Price to Book Value: 2.425 for Dec. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 03, 2024 | 2.468 |
| December 02, 2024 | 2.614 |
| November 29, 2024 | 2.662 |
| November 27, 2024 | 2.574 |
| November 26, 2024 | 2.562 |
| November 25, 2024 | 2.540 |
| November 22, 2024 | 2.560 |
| November 21, 2024 | 2.582 |
| November 20, 2024 | 2.502 |
| November 19, 2024 | 2.551 |
| November 18, 2024 | 2.614 |
| November 15, 2024 | 2.708 |
| November 14, 2024 | 2.851 |
| November 13, 2024 | 2.954 |
| November 12, 2024 | 3.046 |
| November 11, 2024 | 3.186 |
| November 08, 2024 | 3.112 |
| November 07, 2024 | 3.134 |
| November 06, 2024 | 3.135 |
| November 05, 2024 | 2.933 |
| November 04, 2024 | 2.898 |
| November 01, 2024 | 2.893 |
| October 31, 2024 | 2.975 |
| October 30, 2024 | 2.952 |
| October 29, 2024 | 3.052 |
| Date | Value |
|---|---|
| October 28, 2024 | 3.129 |
| October 25, 2024 | 3.112 |
| October 24, 2024 | 3.203 |
| October 23, 2024 | 3.249 |
| October 22, 2024 | 3.246 |
| October 21, 2024 | 3.320 |
| October 18, 2024 | 3.346 |
| October 17, 2024 | 2.933 |
| October 16, 2024 | 2.921 |
| October 15, 2024 | 2.81 |
| October 14, 2024 | 2.659 |
| October 11, 2024 | 2.588 |
| October 10, 2024 | 2.402 |
| October 09, 2024 | 2.371 |
| October 08, 2024 | 2.408 |
| October 07, 2024 | 2.402 |
| October 04, 2024 | 2.485 |
| October 03, 2024 | 2.488 |
| October 02, 2024 | 2.491 |
| October 01, 2024 | 2.445 |
| September 30, 2024 | 2.539 |
| September 27, 2024 | 2.340 |
| September 26, 2024 | 2.334 |
| September 25, 2024 | 2.241 |
| September 24, 2024 | 2.358 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.549
Minimum
Mar 18 2024
4.612
Maximum
Aug 17 2022
2.647
Average
2.561
Median
Price to Book Value Benchmarks
| Fulcrum Therapeutics Inc | 0.7358 |
| Moderna Inc | 1.343 |
| NovaBay Pharmaceuticals Inc | 2.533 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.391 |
Price to Book Value Related Metrics
| Price | 8.48 |
| Earnings Yield | -20.40% |
| Market Cap | 423.59M |